Tower Research Capital (TRC)’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-316
| Closed | -$2.37K | – | 5656 |
|
2024
Q4 | $2.37K | Buy |
+316
| New | +$2.37K | ﹤0.01% | 4855 |
|
2024
Q2 | – | Sell |
-103
| Closed | -$879 | – | 5940 |
|
2024
Q1 | $879 | Sell |
103
-312
| -75% | -$2.66K | ﹤0.01% | 5368 |
|
2023
Q4 | $3.52K | Buy |
+415
| New | +$3.52K | ﹤0.01% | 5069 |
|
2023
Q3 | – | Sell |
-3,004
| Closed | -$39.1K | – | 6151 |
|
2023
Q2 | $39.1K | Buy |
3,004
+2,688
| +851% | +$35K | ﹤0.01% | 2770 |
|
2023
Q1 | $3K | Buy |
+316
| New | +$3K | ﹤0.01% | 5227 |
|
2022
Q4 | – | Sell |
-3,100
| Closed | -$13K | – | 6259 |
|
2022
Q3 | $13K | Buy |
3,100
+1,047
| +51% | +$4.39K | ﹤0.01% | 4281 |
|
2022
Q2 | $15K | Buy |
2,053
+1,917
| +1,410% | +$14K | ﹤0.01% | 4086 |
|
2022
Q1 | $1K | Sell |
136
-127
| -48% | -$934 | ﹤0.01% | 5840 |
|
2021
Q4 | $3K | Buy |
+263
| New | +$3K | ﹤0.01% | 5477 |
|
2021
Q3 | – | Sell |
-530
| Closed | -$9K | – | 6076 |
|
2021
Q2 | $9K | Buy |
530
+473
| +830% | +$8.03K | ﹤0.01% | 4445 |
|
2021
Q1 | $1K | Buy |
+57
| New | +$1K | ﹤0.01% | 5204 |
|